Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".
作者信息
Grisanti Salvatore, Bartz-Schmidt Karl-Ulrich, Heimann Heinrich, Lommatzsch Albrecht, Walter Peter, Ach Thomas
机构信息
Department of Ophthalmology, University of Luebeck, University Medical Center Schleswig-Holstein, Luebeck, Germany.
University Eye Hospital, Center of Ophthalmology, University Hospital Tuebingen, Eberhard-Carls University Tuebingen, Tuebingen, Germany.
出版信息
Ophthalmol Ther. 2024 Apr;13(4):1051-1053. doi: 10.1007/s40123-024-00894-2. Epub 2024 Feb 6.
Abstract
摘要
相似文献
1
Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".致编辑的信：关于“LIGHTSITE II随机多中心试验：非渗出性年龄相关性黄斑变性的多波长光生物调节评估”
Ophthalmol Ther. 2024 Apr;13(4):1051-1053. doi: 10.1007/s40123-024-00894-2. Epub 2024 Feb 6.
2
LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration.LIGHTSITE II随机多中心试验：非渗出性年龄相关性黄斑变性的多波长光生物调节评估
Ophthalmol Ther. 2023 Apr;12(2):953-968. doi: 10.1007/s40123-022-00640-6. Epub 2023 Jan 2.
3
A Response to: Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".对《致编辑的信：关于“LIGHTSITE II随机多中心试验：非渗出性年龄相关性黄斑变性的多波长光生物调节评估”》的回复
Ophthalmol Ther. 2024 Apr;13(4):1055-1060. doi: 10.1007/s40123-024-00896-0. Epub 2024 Feb 6.
4
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.LIGHTSITE III：使用Lumithera Valeda光传输系统对非渗出性（干性）年龄相关性黄斑变性进行多波长光生物调节的13个月疗效和安全性评估。
Retina. 2024 Mar 1;44(3):487-497. doi: 10.1097/IAE.0000000000003980.
5
Correspondence.
Retina. 2024 Dec 1;44(12):e81-e83. doi: 10.1097/IAE.0000000000004265.
6
A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.一项采用光生物调节治疗与年龄相关干性黄斑变性的双盲、随机、假对照、单中心研究。
Retina. 2020 Aug;40(8):1471-1482. doi: 10.1097/IAE.0000000000002632.
7
Reply.回复。
Retina. 2024 Dec 1;44(12):e83-e87. doi: 10.1097/IAE.0000000000004266. Epub 2024 Nov 12.
8
Photobiomodulation therapy in age-related macular degeneration.光生物调节疗法治疗年龄相关性黄斑变性。
Curr Opin Ophthalmol. 2021 May 1;32(3):225-232. doi: 10.1097/ICU.0000000000000742.
9
Photobiomodulation for non-exudative age-related macular degeneration.光生物调节治疗非渗出性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2021 May 6;5(5):CD013029. doi: 10.1002/14651858.CD013029.pub2.
10
Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration.光生物调节可减少干性年龄相关性黄斑变性患者的玻璃膜疣体积，并提高视力和对比敏感度。
Acta Ophthalmol. 2017 Jun;95(4):e270-e277. doi: 10.1111/aos.13354. Epub 2016 Dec 18.
引用本文的文献
1
[Photobiomodulation for AMD : Statement of the German Society of Ophthalmology, the German Retina Society and the German Professional Association of Ophthalmologists. Status 4 July 2025].[用于年龄相关性黄斑变性的光生物调节：德国眼科学会、德国视网膜学会和德国眼科医生专业协会声明。2025年7月4日状态]
Ophthalmologie. 2025 Sep 1. doi: 10.1007/s00347-025-02303-w.
本文引用的文献
1
LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration.LIGHTSITE II随机多中心试验：非渗出性年龄相关性黄斑变性的多波长光生物调节评估
Ophthalmol Ther. 2023 Apr;12(2):953-968. doi: 10.1007/s40123-022-00640-6. Epub 2023 Jan 2.
2
Photobiomodulation for non-exudative age-related macular degeneration.光生物调节治疗非渗出性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2021 May 6;5(5):CD013029. doi: 10.1002/14651858.CD013029.pub2.
3
A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.一项采用光生物调节治疗与年龄相关干性黄斑变性的双盲、随机、假对照、单中心研究。
Retina. 2020 Aug;40(8):1471-1482. doi: 10.1097/IAE.0000000000002632.
4
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.年龄相关性黄斑变性继发的地图样萎缩进展。
Ophthalmology. 2018 Mar;125(3):369-390. doi: 10.1016/j.ophtha.2017.08.038. Epub 2017 Oct 27.
5
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.年龄相关性黄斑变性所致地图样萎缩的长期自然病程：萎缩范围扩大及其对干预性临床试验的意义
Ophthalmology. 2007 Feb;114(2):271-7. doi: 10.1016/j.ophtha.2006.09.016.
Zotero 插件